Angioimmunoblastic T-cell lymphoma (AITL) is a rare and aggressive type of non-Hodgkin's lymphoma (NHL) that affects the immune system's T-cells. It is often diagnosed in older adults and presents with a variety of symptoms, making it difficult to diagnose.
AITL is characterized by enlarged lymph nodes, fever, night sweats, weight loss, and skin rashes, which are similar to other types of lymphoma. However, patients with AITL often have additional symptoms like anemia, low platelet count, and elevated liver enzymes.
The exact cause of AITL is still unknown, but experts believe it may be related to a genetic mutation in the T-cells. Exposure to certain viruses and chemicals may also increase the risk of developing AITL.
Since AITL is a rare type of NHL, diagnosis can be challenging. Doctors may perform a variety of tests, including a physical examination, blood tests, imaging tests, and a biopsy of the affected tissue, to confirm the diagnosis.
Patients with AITL may receive chemotherapy, radiation therapy, or a combination of both to treat the disease. However, the prognosis for AITL is generally poor, and the disease often recurs even after treatment.
Angioimmunoblastic T-cell lymphoma is a rare and aggressive type of non-Hodgkin's lymphoma that affects the immune system's T-cells. It can be difficult to diagnose due to its varied symptoms and is often diagnosed in older adults. While treatment options exist, the prognosis for AITL is generally poor, and patients require ongoing care and monitoring.
To see full information about treatment please Sign up or Log in